Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results in adu ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

Company's chairman Ashok Hinduja on Tuesday said that the bank has the full support of the promoters and if there is any need for further capital to be raised, the promoters are ready to inject.

The study met its primary endpoint, but analysts compared the results unfavorably to the data on Dupixent. Adjusted for placebo, 19.1% of people on rocatinlimab had 75% improvement in eczema area ...

You’ll typically inject semaglutide once per week, on the same day each week. Your doctor may increase your dose after 4 weeks if necessary. It’s important not to stop taking semaglutide ...

Positive results from the ADEPT Phase II/III study indicate that Dupixent (dupilumab) may be effective in treating moderate-to-severe bullous pemphigoid (BP). The findings were presented at the 2025 ...

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi presented positive results from the pivotal ADEPT Phase 2/3 trial evaluating the investigational use of Dupixent (dupilumab) in adults ...

They’ll also explain how much to take and how often to inject it. Be sure to follow your doctor’s instructions. Ozempic comes as a liquid solution inside prefilled, disposable pens.

The injection pen market is known as a highly competitive market and consists ... real-time1 Guardian Connect CGM data was announced by Medtronic plc. In April 2020, Dupixent, a novel prefilled pen ...